Is a complete OTLK research report available?

No complete published report is available for Outlook Therapeutics, Inc. (OTLK) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · USD

$1.41

+0.09 (+6.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first OTLK analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	262.7M
Revenue (ttm)	333.1K
Net income (ttm)	-61M
EPS (ttm)	-$1.08
Shares out	187M
Volume	57,888,076
Beta	0.78
Price target	$5.50	+291.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 333.1K
Net income (ttm): -61M
EPS (ttm): -$1.08
Market cap: 262.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All OTLK indicators

Market & fundamental data

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001649989
Company name	Outlook Therapeutics, Inc.
Country	United States
Country code	US
Cusip	69012T305
Employees	17
Employees Change	-6%
Employees Change Percent	-26.09
Enterprise value	$282.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2016-05-13
Isin	US69012T3059
Last refreshed	2026-07-25
Market cap	$262.7M
Market cap category	Micro-Cap
Price	$1.41
Price currency	USD
Rev Per Employee	19,596.53x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2836
Symbol	OTLK
Website	https://outlooktherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.2%
EV Sales Forward	28.94x
EV/Sales	847x
FCF yield	-17.91%
P/S ratio	788.65x
PS Forward	26.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-18,182.76%
EBITDA Margin	-18,146.85%
Gross Profit	$-1.2M
Net Income	$-61M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-18,764.16%
Profit Per Employee	$-3.6M
ROA	-184.8
Roa5y	-147.6
ROCE	356.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-44.67%
Cagr1y	-32.47%
Cagr3y	-65.62%
Cagr5y	-50.74%
EPS Growth Quarters	1
EPS Growth Years	10
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$21.9M
Cash	$7.7M
Current Assets	$20.9M
Current Liabilities	$38.9M
Debt	$27.2M
Equity	$-29M
Interest Coverage	-213.9
Liabilities	$50.9M
Long Term Assets	$987,695
Long Term Liabilities	$12M
Net Cash	$-19.4M
Net Cash By Market Cap	$-7.4
Tangible Book Value	$-29M
Tangible Book Value Per Share	$-0.28
WACC	7.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.54
Inventory Turnover	0.44
Net Working Capital	$-9.8M
Quick ratio	0.27
Working Capital	$-18M
Working Capital Turnover	$-0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-121.62%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.73%
1Y total return	-32.45%
200-day SMA	0.94
3Y total return	-95.94%
50-day SMA	1.13
50-day SMA vs 200-day SMA	50over200
5Y total return	-97.1%
All Time High	878.4
All Time High Change	-99.84%
All Time High Date	2016-09-01
All Time Low	0.16
All Time Low Change	772.13%
All Time Low Date	2026-03-24
ATR	0.2
Beta	0.78
Beta1y	3.15
Beta2y	1.42
Ch YTD	-11.08
High	1.75
High52	3.39
High52 Date	2025-08-26
High52ch	-58.55%
Low	1.12
Low52	0.16
Low52 Date	2026-03-24
Low52ch	772.13%
Ma50ch	24.89%
Premarket Change Percent	2.27
Premarket Price	$1.35
Premarket Volume	175,697
Price vs 200-day SMA	49.39%
RSI	50.84
RSI Monthly	39.45
RSI Weekly	62.28
Sharpe ratio	0.64x
Sortino ratio	0.96
Total Return	-121.62%
Tr YTD	-11.08
Tr1m	-17.35%
Tr1w	1.08%
Tr3m	389.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$1.06
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.09
Earnings Revenue Estimate	500,000x
Earnings Revenue Estimate Growth	-66.78x
Operating Income	$-60.6M
Operating margin	-18,182.8
Price target	$5.5
Price Target Change	$291
Price Target Change Top	$-24.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	162,532,513%
Float Percent	86.92%
Net Borrowing	-3,232,558
Shares Insiders	0.36%
Shares Institutions	8.59%
Shares Out	186,996,998
Shares Qo Q	35.93%
Shares Yo Y	121.62%
Short Float	8.62%
Short Ratio	0.73
Short Shares	7.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-52.2M
Average Volume	10,668,603.7x
Bv Per Share	-0.28
Ch10y	-99.73
Ch1m	-17.35
Ch1w	1.08
Ch1y	-32.45
Ch3m	389.7
Ch3y	-95.94
Ch5y	-97.1
Ch6m	179.3
Change	6.44%
Change From Open	4.07
Close	1.32
Days Gap	2.27
Depreciation Amortization	119,640
Dollar Volume	81,332,746.8
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-60.6M
EBITDA	$-60.5M
EPS	$-1.08
F Score	2
FCF	$-47M
FCF EV Yield	-16.67x
FCF Per Share	$-0.25
Financing CF	47,237,435
Fiscal Year End	September
Founded	2,010
Income Tax	$-1.6M
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2024-03-14
Last Split Type	Reverse
Last10k Filing Date	2025-12-19
Ma150	0.73
Ma150ch	92.94%
Ma20	1.51
Ma20ch	-7.2%
Net CF	191,913
Next Earnings Date	2026-08-13
Open	1.35
Optionable	Yes
Position In Range	45.24
Post Close	1.41
Postmarket Change Percent	-0.36
Postmarket Price	$1.4
Ppne	198,975
Pre Close	1.32
Price Date	2026-07-24
Relative Volume	5.43x
Revenue	333,141x
SBC By Revenue	1,543.29x
Share Based Comp	5,141,323
Tax By Revenue	-466.66x
Tr6m	179.32%
Us State	New Jersey
Views	906
Volume	57,888,076
Z Score	-49.88

Outlook Therapeutics, Inc. (OTLK)

Coverage state: Market snapshot only — no published research

Generate the first OTLK analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · OTLK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OTLK indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on OTLK

Frequently asked questions